# US 8,278,435 B2 · N-pyrazole A2A receptor agonists

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,435 B2
- Document ID: US8278435B2
- Status: Granted
- Kind: B2
- Application number: 12/968,110
- Filed: 2010-12-14
- Published: 2011-06-16
- Granted: 2012-10-02
- Earliest claimed: 1999-06-22
- Assignees: Gilead Sciences, Inc.
- Inventors: Jeff A. Zablocki; Elfatih O. Elzein; Venkata Palle; Luiz Belardinelli
- Web page: https://patentgrep.com/patent/US8278435B2

## CPC

- C07H 19/16: Purine radicals
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/08: Vasodilators for multiple indications
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 473/34: attached in position 6, e.g. adenine
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present disclosure provides a process for the preparation of 2-adenosine N-pyrazole compounds exemplified by the structure shown below that are potent and selective agonists for A2A adenosine receptor, compositions comprising these compounds, and methods for using these compounds to stimulate mammalian coronary vasodilation for imaging the heart.

## Claims

### Claim 1

A method for the preparation of (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide:
comprising heating a compound of formula 10:
in excess methylamine to provide (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method comprises an aqueous solution of methylamine.

### Claim 3 (depends on 1)

The method of claim 1, wherein the method comprises heating at a temperature of about 65° C.

### Claim 4 (depends on 1)

The method of claim 1, wherein the method comprises an aqueous solution of methylamine and heating at a temperature of about 65° C.

### Claim 5 (depends on 1)

The method of claim 1, wherein the method further comprises preparing the compound of formula 10:
by reacting a compound of formula 1:
with ethoxycarbonylmalondialdehyde.

### Claim 6 (depends on 5)

The method of claim 5, wherein preparing the compound of formula 10 comprises a temperature of about 80° C.

### Claim 7 (depends on 5)

The method of claim 5, wherein preparing the compound of formula 10 comprises a mixture of CH3OH and CH3COOH as a solvent.

### Claim 8 (depends on 7)

The method of claim 7, wherein the mixture of CH3OH and CH3COOH is in a 1:1 ratio.

### Claim 9 (depends on 5)

The method of claim 5, wherein preparing the compound of formula 10 comprises a temperature of about 80° C. and a 1:1 mixture of CH3OH and CH3COOH as a solvent.

### Claim 10 (depends on 5)

The method of claim 5, wherein the method further comprises preparing the compound of formula 1:
by reacting a compound of formula 9:
with hydrazine hydrate.

### Claim 11 (depends on 10)

The method of claim 10, wherein the method further comprises preparing the compound of formula 9:
by reacting a compound of formula 8:
with NH3.

### Claim 12 (depends on 11)

The method of claim 11, wherein the method further comprises preparing the compound of formula 8:
by reacting a compound of formula 7:
with CH3(CH2)4ONO and CH2I2.

### Claim 13 (depends on 12)

The method of claim 12, wherein the method further comprises preparing the compound of formula 7:
by reacting a compound of formula 6:
with POCl3.

### Claim 14 (depends on 13)

The method of claim 13, wherein the method further comprises preparing the compound of formula 6:
by reacting guanosine:
with acetic anhydride.
